Bristol to Pay $13.1 Billion for Heart-Drug Maker MyoKardia

0
4

Bristol Myers Squibb Co. said it will buy biotech MyoKardia Inc. in a $13.1 billion deal aimed at expanding the cancer-drug powerhouse’s lineup of heart drugs.

The all-cash deal would snag MyoKardia’s promising experimental heart drug, which if approved would allow Bristol to lessen its reliance on cancer therapies—heavier since the company’s $74 billion acquisition of multiple-myeloma drug leader Celgene Corp. last year.

Source: https://www.wsj.com/articles/bristol-to-pay-13-1-billion-for-heart-drug-maker-myokardia-11601892902

Bristol Myers Squibb, MyoKardia, Heart, NASDAQ:MYOK, NYSE:BMY

Actu monde – US – Bristol to Pay $13.1 Billion for Heart-Drug Maker MyoKardia

Abonnez-vous à notre chaîne Youtube en cliquant ici

Vidéo du jour: De la cocaïne retrouvée dans une école maternelle de Seine Saint Denis, deux enfants hospitalisés

– Pub –